pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
789
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
FT-576
Refractory Multiple Myeloma
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-825
Colorectal Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
← prev
page 10 of 27
next →
131
Pain
89
Neurology
1
FT-836
Breast Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
G-207
Anaplastic Astrocytoma
Treovir LLC
0
catalysts
Phase 1
GC-1130A
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
GC Biopharma Corp
0
catalysts
Phase 1
GIGA-2339
Hepatitis B
$GRFS
Grifols SA
0
catalysts
Phase 1
GIGA-564
Solid Tumor
GigaGen Inc
0
catalysts
Phase 1
GM-60106
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
JD Bioscience Inc
0
catalysts
Phase 1
GMA-301
Pulmonary Arterial Hypertension
Gmax Biopharm LLC
0
catalysts
Phase 1
GNS-3545
Idiopathic Pulmonary Fibrosis
Genosco Inc
0
catalysts
Phase 1
GNSC-001
Osteoarthritis
Genascence Corp
0
catalysts
Phase 1
GNTI-122
Type 1 Diabetes (Juvenile Diabetes)
GentiBio Inc
0
catalysts
Phase 1
GRC-39815
Chronic Obstructive Pulmonary Disease (COPD)
Glenmark Pharmaceuticals Ltd
0
catalysts
Phase 1
GRN-300
Triple-Negative Breast Cancer (TNBC)
Greenfire Bio LLC
0
catalysts
Phase 1
GS-0321
Solid Tumor
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
GT-01
Obesity
Gila Therapeutics Inc
0
catalysts
Phase 1
GTB-3650
Myelodysplastic Syndrome (Preleukemia)
$GTBP
GT Biopharma, Inc.
0
catalysts
Phase 1
GTB-5550
Epithelial Ovarian Cancer
$GTBP
GT Biopharma, Inc.
0
catalysts
Phase 1
Gallium Maltolate
Recurrent Glioblastoma Multiforme (GBM)
$KMCM
Titan Holdings Corp.
0
catalysts
Phase 1
Gene Therapy to Target CD22 for Oncology
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
National Cancer Institute US
0
catalysts
Phase 1
H-100
H100
Peyronies Disease
$PTPI
Petros Pharmaceuticals, Inc.
0
catalysts
Phase 1
H-3B6545
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Eisai Co Ltd
0
catalysts
Phase 1
HBM-1020
Metastatic Colorectal Cancer
Harbour BioMed (Guangzhou) Co Ltd
0
catalysts
Phase 1
HCB-301
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
HanchorBio Inc
0
catalysts
Phase 1
HCW-9302
Alopecia Areata
$HCWB
HCW Biologics Inc.
0
catalysts
Phase 1
HDT-321
Crimean-Congo Hemorrhagic Fever
HDT Bio Corp
0
catalysts
Phase 1
HF-158K1
Bladder Cancer
HighField Biopharmaceuticals, Inc.
0
catalysts
Phase 1
HFB-200603
Colorectal Cancer
HiFiBiO Therapeutics Inc
0
catalysts
